| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 22/01/2025 | 21:56 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:RXST | RxSight Inc |
| 12/01/2025 | 15:30 | GlobeNewswire Inc. | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance | NASDAQ:RXST | RxSight Inc |
| 02/01/2025 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference | NASDAQ:RXST | RxSight Inc |
| 04/12/2024 | 00:38 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:RXST | RxSight Inc |
| 14/11/2024 | 23:46 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] | NASDAQ:RXST | RxSight Inc |
| 07/11/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. Reports Third Quarter 2024 Financial Results | NASDAQ:RXST | RxSight Inc |
| 24/10/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024 | NASDAQ:RXST | RxSight Inc |
| 22/08/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences | NASDAQ:RXST | RxSight Inc |
| 05/08/2024 | 22:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:RXST | RxSight Inc |
| 05/08/2024 | 22:10 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:RXST | RxSight Inc |
| 05/08/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. Reports Second Quarter 2024 Financial Results | NASDAQ:RXST | RxSight Inc |
| 22/07/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 | NASDAQ:RXST | RxSight Inc |
| 05/06/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. To Participate in the Truist Securities Medtech Conference | NASDAQ:RXST | RxSight Inc |
| 16/05/2024 | 22:30 | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NASDAQ:RXST | RxSight Inc |
| 13/05/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares | NASDAQ:RXST | RxSight Inc |
| 09/05/2024 | 22:59 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:RXST | RxSight Inc |
| 09/05/2024 | 03:15 | GlobeNewswire Inc. | RxSight, Inc. Announces Pricing of Public Offering of Common Stock | NASDAQ:RXST | RxSight Inc |
| 08/05/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. Announces Proposed Public Offering of Common Stock | NASDAQ:RXST | RxSight Inc |
| 08/05/2024 | 22:01 | Edgar (US Regulatory) | Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers | NASDAQ:RXST | RxSight Inc |
| 06/05/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. Reports First Quarter 2024 Financial Results | NASDAQ:RXST | RxSight Inc |
| 01/05/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. to Present at the Bank of America Healthcare Conference | NASDAQ:RXST | RxSight Inc |
| 22/04/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024 | NASDAQ:RXST | RxSight Inc |
| 04/04/2024 | 22:05 | GlobeNewswire Inc. | RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting | NASDAQ:RXST | RxSight Inc |
| 27/03/2024 | 21:05 | GlobeNewswire Inc. | RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference | NASDAQ:RXST | RxSight Inc |
| 01/03/2024 | 01:05 | GlobeNewswire Inc. | RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference | NASDAQ:RXST | RxSight Inc |
| 28/02/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | NASDAQ:RXST | RxSight Inc |
| 14/02/2024 | 23:01 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:RXST | RxSight Inc |
| 14/02/2024 | 22:05 | GlobeNewswire Inc. | RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 | NASDAQ:RXST | RxSight Inc |
| 29/01/2024 | 23:25 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:RXST | RxSight Inc |
| 07/01/2024 | 16:00 | GlobeNewswire Inc. | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance | NASDAQ:RXST | RxSight Inc |